Company: MDCXW
Filing Date: 2025-06-30
Form Type: DEF 14A
Source: 0001062993-25-012273
Chunk: 18

Company: Medicus Pharma Ltd.
Filing Date: 2025-06-30
Form: DEF 14A
Chunk 18
---
8
1- 888-290-1175</div>

How do I obtain additional copies of this proxy statement or voting materials?

If you need additional copies of this proxy statement or the proxy materials, please contact us at:

<div align='center'>Medicus Pharma Ltd.
Attn: Corporate Secretary
300 Conshohocken State Rd. Suite 200
W. Conshohocken, PA 19428
M5X 1A4
madesso@medicuspharma.com

OVERVIEW OF PROPOSALS TO BE VOTED ON</div>

Proposals 1, 2, 3, 4 and 5 are included in this proxy statement at the direction of the Board. The Board unanimously recommends that you vote "" the appointment and remuneration of auditors in Proposal 1, "" the election of the nominees in Proposal 2, "" the Quorum Amendment in Proposal 3, "" the approval of the issuance of shares pursuant to the SEPA in accordance with the Nasdaq 20% Rule in Proposal 4, and " the Chairman Amendment in Proposal 5.

<div align='center'>PRESENTATION OF FINANCIAL STATEMENTS</div>

The Company's audited consolidated financial statements as of and for the years ended December 31, 2024 and December 31, 2023, together with the auditor's report thereon, will be presented to the Shareholders at the Meeting. The Company's audited consolidated financial statements as of and for the years ended December 31, 2024 and December 31, 2023 are also available on the Company's website at www.medicuspharma.com.

<div align='center'>- 17 -</div>

Audit Committee Report

The material in this report is not "soliciting material," is not deemed "filed" with the SEC, and is not to be incorporated by reference into any filing by Medicus Pharma Ltd. under the Securities Act of 1933, as amended, or the Exchange Act.

The audit committee of the Board (the "Audit Committee") has reviewed and discussed the audited financial statements for the year ended December 31, 2024 with management. The Audit Committee has also discussed with EisnerAmper LLP ("EisnerAmper"), the Company's prior independent registered public accounting firm, the matters required to be discussed under applicable auditing standards, including Auditing Standard No. 1301. In addition, the Audit Committee discussed with